Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Gross Goupil

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Cancer Treatment Reviews|February 15, 2012
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinomaAlain Ravaud, Marine Gross-Goupil
Medecine Sciences : M/S|September 16, 2008
[Revolution in treatment of renal carcinoma: molecular rational and clinical approach]Bernard Escudier, Marine Gross-Goupil
Bulletin Du Cancer|July 5, 2020
[Innovations in systemic treatment of urothelial carcinoma]Constance Thibault, Marine Gross-Goupil
Translational Andrology and Urology|January 28, 2016
Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?Marine Gross-Goupil, Alain Ravaud
Current Urology Reports|December 6, 2011
Targeted therapies in metastatic renal cell carcinoma: overview of the past yearMarine Gross-Goupil, Christophe Massard, Alain Ravaud
Clinical Genitourinary Cancer|February 15, 2014
Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinomaAmaury Daste, Marine Gross-Goupil, Alain Ravaud
Seminars in Oncology|August 27, 2013
Combination therapy in metastatic renal cell cancerAlain Ravaud, Marine Gross-Goupil, Joaquim Bellmunt
Expert Opinion on Investigational Drugs|August 11, 2012
Lapatinib and renal cell carcinomaMarine Gross-Goupil, Jean-Christophe Bernhard, Alain Ravaud
Bulletin Du Cancer|July 5, 2020
Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAveMarine Gross-Goupil, Charlotte Domblides, Felix Lefort, et al.
Bulletin Du Cancer|April 24, 2012
[Strategy in advanced castration-resistant prostate cancer]Marine Gross-Goupil, Sophie Roca, Gilles Pasticier, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Cancer Treatment Reviews|February 15, 2012
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinomaAlain Ravaud, Marine Gross-Goupil
Medecine Sciences : M/S|September 16, 2008
[Revolution in treatment of renal carcinoma: molecular rational and clinical approach]Bernard Escudier, Marine Gross-Goupil
Bulletin Du Cancer|July 5, 2020
[Innovations in systemic treatment of urothelial carcinoma]Constance Thibault, Marine Gross-Goupil
Translational Andrology and Urology|January 28, 2016
Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?Marine Gross-Goupil, Alain Ravaud
Current Urology Reports|December 6, 2011
Targeted therapies in metastatic renal cell carcinoma: overview of the past yearMarine Gross-Goupil, Christophe Massard, Alain Ravaud
Clinical Genitourinary Cancer|February 15, 2014
Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinomaAmaury Daste, Marine Gross-Goupil, Alain Ravaud
Seminars in Oncology|August 27, 2013
Combination therapy in metastatic renal cell cancerAlain Ravaud, Marine Gross-Goupil, Joaquim Bellmunt
Expert Opinion on Investigational Drugs|August 11, 2012
Lapatinib and renal cell carcinomaMarine Gross-Goupil, Jean-Christophe Bernhard, Alain Ravaud
Bulletin Du Cancer|July 5, 2020
Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAveMarine Gross-Goupil, Charlotte Domblides, Felix Lefort, et al.
Bulletin Du Cancer|April 24, 2012
[Strategy in advanced castration-resistant prostate cancer]Marine Gross-Goupil, Sophie Roca, Gilles Pasticier, et al.
Pageof 16